Navigation Links
Facet Solution's AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up
Date:10/15/2007

LOGAN, Utah, Oct. 15 /PRNewswire/ -- Facet Solutions, Inc. announced today that it has completed one year follow-up on the first cohort of patients to receive its Anatomic Facet Replacement System (AFRS(TM)). The clinical outcomes for these patients at one year include a significant decline in leg and back pain; improved motion and function; and no post-operative complications. Additionally, the first patient in the AFRS(TM) study has completed the two year follow up evaluation with similarly positive results.

The AFRS(TM) has been developed by Facet Solutions, Inc. to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to lumbar spinal fusion. The AFRS(TM) procedure includes replacing the diseased facet joint with an anatomic implant that restores the natural motion, stability, and balance to the lumbar spine.

An international team of Orthopedic surgeons began the initial AFRS(TM) study at the Hospital Servidor Publico Estadol in Sao Paulo in late September 2005. The team included Dr. Allen Carl of Albany Medical Center in Albany, New York and Dr. Carlos Oliveira of Sao Paulo, Brazil.

"I believe that the early clinical results for the AFRS(TM) clearly demonstrate that this new treatment option is improving the quality of life for my patients who would otherwise lose significant motion using current fusion or dynamic stabilization devices," Dr. Oliviera stated. "In fact, many of my patients were having fusions and would come back four and five years later needing a subsequent fusion at adjacent levels as a result of the reduction in motion at the original fused level of the spine. I anticipate that this technology will ultimately become the surgical standard of care for spinal stenosis patients in the future."

"Facet Solutions is very pleased with the early clinical experience," added Eric Bannon, VP of Clinical Affairs. "The company looks forward to expanding this clinical outcome data with results from an ongoing FDA approved IDE Study which was recently expanded to eight sites within the United States."

The summary findings from this evaluation will be presented a the Science of Facet Joint Repair and Total Posterior Arthroplasty Symposium which will be held in Austin, Texas at the Omni Hotel on Monday, October 22, 2007 at 6:30 PM.

* Note: AFRS(TM) is an investigational device in the United States. It is

limited by United States (U.S.) Federal Law for investigational use

only.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture backed company that is focused on developing and commercializing surgical devices for the treatment of facet related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is FDA registered and is certified to ISO 13485.


'/>"/>
SOURCE Facet Solutions, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. The many facets of milk and its health potential
2. The Multi-Faceted Chemical Benzene
3. Multifaceted Stress: Mere thought is stressful!
4. Solutions Being Sought For Prevention Of Rickets
5. Mental Hospitals Offer More Problems than Solutions
6. Sex Workers Adopt IT Solutions to Fight AIDS
7. Bilcare Signs Pact With Honeywell for Packaging Solutions
8. Planning for Good Health Resolutions
9. Simple Solutions to Postpartum Weight Retention
10. Solutions Possible for Providing Water and Sanitation in Poor Urban Settlements, Says WaterAid
11. Silicon eye implants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... A recent Bellwether Education Partners’ ... the field must first improve teacher preparation program design. It then asserts that ... that decades of input- and outcome-based research has failed to improve teacher education. ...
(Date:3/28/2017)... ... March 28, 2017 , ... India’s ... technology to directly address the resolution to globally reduce the harmful use of ... compound of FDA and TTB approved ingredients that when infused into alcohol, renders ...
(Date:3/28/2017)... WASHINGTON, DC (PRWEB) , ... March 28, 2017 ... ... call on elected representatives in state legislatures and Congress to protect parental rights ... the public health and safety in America. , The demonstration coincides with a ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of all holidays (IBT World Travel Trends Report). As travelers visit both urban ... range in temperatures, and prolonged sun exposure. In response, the outdoor industry has ...
(Date:3/28/2017)... ... 2017 , ... Via Oncology, the leading provider of oncology ... public-facing tool for analyzing the costs of various drug regimens in cancer care. ... patients, providers, insurers and pharmaceutical companies about the estimated costs of treatment options. ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... DUBLIN , Mar 29, 2017 Research ... Global Market - Forecast to 2023" report to their offering. ... The ablation ... CAGR to reach $20,995.5 million by 2023. Ablation ... wide range of purposes, from cancerous or diseased tissue removal, to ...
(Date:3/29/2017)...  Spiral Therapeutics, Inc. today announced the signature ... for the worldwide exclusive rights to Bionure,s lead ... of otolaryngology for aggregate payments of up to ... provides Spiral with the option to license two ... Under the terms of the agreement, Spiral will ...
(Date:3/29/2017)... 2017   Royal Philips (NYSE: PHG, ... and PathAI, a company that develops artificial intelligence ... to develop solutions that improve the precision and ... diseases. The partnership aims to build deep learning ... artificial intelligence to be applied to massive pathology ...
Breaking Medicine Technology: